Press Releases
CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.
February 22, 2018
California’s Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
California’s Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
January 18, 2018
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
January 17, 2018
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
December 14, 2017
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
November 30, 2017
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
October 26, 2017
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
October 2, 2017
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
September 28, 2017
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
August 24, 2017
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
July 20, 2017
Phase 3 Clinical Trial Targeting Lou Gehrig’s Disease Gets $15.9 Million Investment From Stem Cell Agency
Phase 3 Clinical Trial Targeting Lou Gehrig’s Disease Gets $15.9 Million Investment From Stem Cell Agency
June 29, 2017
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
June 12, 2017
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board
April 7, 2017
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
March 23, 2017
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
February 23, 2017
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
January 19, 2017
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
December 13, 2016
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
December 5, 2016
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
November 28, 2016
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
November 17, 2016
Stem Cell Agency Focuses Almost $38 Million on Colorectal Cancer, a Deadly Childhood Disorder and High Blood Pressure in the Lungs
Stem Cell Agency Focuses Almost $38 Million on Colorectal Cancer, a Deadly Childhood Disorder and High Blood Pressure in the Lungs
October 19, 2016
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
September 21, 2016
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
July 21, 2016
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
February 18, 2016
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
January 6, 2016
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
December 17, 2015
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future
September 24, 2015
Stem Cell Agency Invests Almost $20 Million in Clinical Trial for Deadly Brain Cancer
Stem Cell Agency Invests Almost $20 Million in Clinical Trial for Deadly Brain Cancer